Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6669721 | 7352712 | F | 6669721-4 | 20100304 | 20100319 | 20100402 | EXP | TCI2010A00976 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 55 | YR | M | N | 20100401 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6669721 | 1013454460 | PS | ACTOS | 1 | ORAL | 30 MG (30 MG, 1 IN 1 D), PER ORAL | N | D | 21073 | ||
| 6669721 | 1013530353 | C | LANSORAL (LANSOPRAZOLE) | 2 | |||||||
| 6669721 | 1013530354 | C | OMEPRAZOLE | 1 | |||||||
| 6669721 | 1013530355 | C | PLETAL | 1 | |||||||
| 6669721 | 1013530356 | C | ALLOPURINOL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6669721 | 1013454460 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6669721 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6669721 | ABDOMINAL DISCOMFORT |
| 6669721 | DECREASED APPETITE |
| 6669721 | GASTRIC CANCER |
| 6669721 | LYMPHADENOPATHY |
| 6669721 | MALIGNANT ASCITES |
| 6669721 | METASTASES TO PERITONEUM |
| 6669721 | PYLORIC STENOSIS |
| 6669721 | REFLUX OESOPHAGITIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6669721 | FGN |
| 6669721 | HP |
| 6669721 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6669721 | 1013454460 | 20071022 | 20100305 | 865 | DAY |